Page 67 - Use Authorization News Today

Three central Ohio hospital systems offered the coronavirus vaccine to employees who work from home, potentially stretching the bounds of what was permitted in the states initial rollout of the shots. Phase 1A of Ohios vaccine rollout identified those first in line to receive the shot as health care workers and personnel who are routinely involved in the care of COVID-19 patients. The state guidelines, published Dec. 15, said "high-risk health care providers" should be prioritized during Phase...

The Kantaro COVID-SeroKlir kit available from EKF Diagnostics is a direct ELISA designed for the quantitative detection of human IgG antibodies to the SARS-CoV-2 virus in samples of serum and plasma (K2-EDTA/Li-Heparin). The COVID-SeroKlir obtained FDA Emergency Use Authorization (EUA) in November 2020 and was earlier awarded a CE mark in October 2020. COVID-SeroKlir has shown a sensitivity of 97.8% and a specificity of 99.6% to detect SARS-CoV-2 specific IgG antibodies against two virus antige...

Share this article Share this article PLYMOUTH MEETING, Pa., Jan. 28, 2021 /PRNewswire/ -- Hundreds of medical products have been authorized for temporary use in the past year to meet the unprecedented need for life-saving equipment and supplies during the COVID-19 pandemic. Today, an internationally respected patient safety organization cautions that meticulous management of these Emergency Use Authorization (EUA) products is crucial to protecting patients, healthcare workers, and hospital op...

Share this article Share this article ABBOTT PARK, Ill., Jan. 27, 2021 /PRNewswire/ -- Abbott (NYSE: ABT) today announced financial results for the fourth quarter and full year ended Dec. 31, 2020, and issued its financial outlook for 2021. Fourth-quarter sales of $10.7 billion increased 28.7 percent on a reported basis and 28.4 percent on an organic basis, which excludes the impact of foreign exchange. Fourth-quarter GAAP diluted EPS was $1.20 and adjusted diluted EPS, which excludes specifi...

(1) SAN DIEGO and BURLINGAME, California, Jan. 27, 2021 /PRNewswire/ -- Ajinomoto Bio-Pharma Services ("Aji Bio-Pharma"), a leading provider of biopharmaceutical contract development and manufacturing services, and Humanigen, Inc. (NASDAQ: HGEN) ("Humanigen"), a clinical-stage biopharmaceutical company focused on preventing and treating an immune hyper-response called cytokine storm with its lead drug candidate lenzilumab, today announced the companies will be expanding their manufacturing agre...

Service members who are preparing to deploy outside of the United States within three months are now eligible to receive their two doses of a vaccine for COVID-19 at Fort George G. Meade.

Service members who are preparing to deploy outside of the United States within three months are now eligible to receive their two doses of a vaccine for COVID-19 at Fort George G. Meade.

Share this article Share this article MONMOUTH JUNCTION, N.J., Jan. 21, 2021 /PRNewswire/ -- CytoSorbents Corporation (NASDAQ: CTSO), a critical care immunotherapy leader commercializing its CytoSorb® blood purification technology to treat deadly inflammation in critically ill and cardiac surgery patients around the world, announces the immediate appointment of David D. Cox, Ph.D., M.B.A., as Vice President – Global Regulatory Affairs. Dr. Cox was most recently Vice President of Regulator...

NEW YORK--(BUSINESS WIRE)--Jan 21, 2021--

Upgrade your face masks: Where to buy N95, KN95 respirators approved by CDC, FDA Updated Feb 17, 2021; At the start of 2021, the Covid-19 pandemic continues to cast its shadow over the United States. Even as the hope of a vaccine finally arrives, new challenges emerge with the arrival of more easily-spread strains of the virus from the United Kingdom and elsewhere. Face masks are now commonplace, and required in most businesses, offices and public places, but many people are still wearing the ...